International Journal of Colorectal Disease

, Volume 31, Issue 7, pp 1367–1368 | Cite as

UbcH10 overexpression is less pronounced in older colorectal cancer patients

  • Gianluca Pellino
  • Pierlorenzo Pallante
  • Umberto Malapelle
  • Angelo Ferraro
  • Claudio Bellevicine
  • Marco Milone
  • Giancarlo Troncone
  • Alfredo Fusco
  • Francesco Selvaggi
  • INSIghT-R Collaborative
Letter to the Editor
First Online:
Accepted:

Keywords

Cetuximab Pearson Coefficient Normal Colonic Tissue Affect Tumor Growth Patient Small Sample 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

The authors thank Dr. Chiara Calabrese and Dr. Nunzio Antonio Cacciola for their invaluable contribution.

Reference

  1. 1.
    Cacciola NA, Calabrese C, Malapelle U, Pellino G, De Stefano A, Sepe R, Sgariglia R, Quintavalle C, Federico A, Bianco A, Uchimura Bastos A, Milone M, Bellevicine C, Milone F, Carlomagno C, Selvaggi F, Troncone G, Fusco A, Pallante P (2015) UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients. Mol Carcinog. doi: 10.1002/mc.22322 PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Gianluca Pellino
    • 1
  • Pierlorenzo Pallante
    • 2
  • Umberto Malapelle
    • 3
  • Angelo Ferraro
    • 4
    • 5
  • Claudio Bellevicine
    • 3
  • Marco Milone
    • 6
  • Giancarlo Troncone
    • 3
  • Alfredo Fusco
    • 2
    • 7
  • Francesco Selvaggi
    • 1
  • INSIghT-R Collaborative
  1. 1.Unit of Colorectal Surgery, Department of Medical, Surgical, Neurological, Metabolic and Geriatric SciencesSecond University of NaplesNaplesItaly
  2. 2.Institute of Experimental Endocrinology and Oncology (IEOS), National Research Council (CNR), c/o Department of Molecular Medicine and Medical Biotechnology (DMMBM)University of Naples “Federico II”NaplesItaly
  3. 3.Department of Public HealthUniversity of Naples “Federico II”NaplesItaly
  4. 4.Institute of Physics, Laboratory of Functional Programmable Materials of Quantum Electronics for BiomedicineKazan Federal UniversityKazanRussia
  5. 5.School of Mining and Metallurgy Engineering, Laboratory of Physical MetallurgyNational Technical University of AthensAthensGreece
  6. 6.Department of Advanced Biomedical SciencesUniversity of Naples “Federico II”NaplesItaly
  7. 7.National Cancer Institute-INCA, Rua Andrè CavalcantiRio de JaneiroBrazil

Personalised recommendations